Related Experiment Video
Updated: Oct 10, 2025

07:23
Using High Content Imaging to Quantify Target Engagement in Adherent Cells
Published on: November 29, 2018
8.7K
Assessing target engagement using proteome-wide solvent shift assays.
Jonathan G Van Vranken1, Jiaming Li1, Dylan C Mitchell1
1Department of Cell Biology, Harvard Medical School, Boston, United States.
Elife
|December 8, 2021
Summary
We developed solvent proteome profiling (SPP), a new method using mass spectrometry to identify drug targets by analyzing protein denaturation. This technique, along with solvent proteome integral solubility alteration (solvent-PISA), enhances drug discovery efficiency.
Area of Science:
- Biochemistry
- Proteomics
- Drug Discovery
Background:
- Quantitative proteomics using mass spectrometry is vital for drug discovery.
- Proteins unfold and precipitate in organic solvents, a process influenced by ligand binding.
- Understanding protein-ligand interactions is key to identifying drug targets.
Purpose of the Study:
- To develop novel proteome-wide assays for target engagement studies in drug discovery.
- To introduce solvent proteome profiling (SPP) and solvent proteome integral solubility alteration (solvent-PISA) as efficient methods.
Main Methods:
- Combined solvent-induced precipitation principles with quantitative mass spectrometry.
- Developed solvent proteome profiling (SPP) to analyze protein denaturation curves.
- Applied area under the curve analysis to create solvent-PISA as a surrogate for SPP.
Main Results:
- Successfully identified specific targets of compounds with known mechanisms of action.
- Demonstrated that solvent-PISA reliably serves as a surrogate for SPP.
- Established SPP's capability in establishing target engagement.
Conclusions:
- SPP and solvent-PISA offer efficient proteome-wide screening for drug target engagement.
- Combining SPP with methods like thermal proteome profiling can increase the number of high-quality binding assays.
- These approaches expand the fraction of the proteome that can be screened for ligand binding, accelerating drug discovery.
Keywords:
biochemistrychemical biologydrug discoveryhumanmass spectrometryproteomicstarget engagement
